# A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-longer-monopoly-for-biologics-considering-the-implications-of-data-exclusivity/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sarah Sorscher |
| Citations | 3 |
| Fields | Economics, Econometrics and Finance,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W271610094 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Sarah Sorscher](https://scholariq.org/researchers/sarah-sorscher/)

## Paper journal

- [Harvard journal of law & technology](https://scholariq.org/journals/harvard-journal-of-law-and-technology/)

## Paper primary topic

- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

## Paper topics

- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Biotechnology and Related Fields](https://scholariq.org/topics/biotechnology-and-related-fields/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.